Dr. Roloff and faculty assess outcomes from the retrospective, multicenter ROCCA analysis (Real-world Outcomes Collaborative of CAR-T in Adult ALL) and propose some social determinants of health SDoH variables that bear further investigation.
ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy
Revisit the OncLive On Air Episodes From February 2024
State of the Science Summit - Hematology: Chaired by Martha Arellano, MD
Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma
FAK Inhibition Emerges as a Potential Complementary Treatment Pathway
Revisit Every OncLive On Air Episode from March 2024
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma